Astec LifeSciences Limited

BSE:533138 Stock Report

Market Cap: ₹21.2b

Astec LifeSciences Past Earnings Performance

Past criteria checks 0/6

Astec LifeSciences's earnings have been declining at an average annual rate of -41.8%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been declining at an average rate of 2% per year.

Key information

-41.8%

Earnings growth rate

-41.8%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate-2.0%
Return on equity-35.5%
Net Margin-27.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Astec LifeSciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:533138 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,729-1,0366140
30 Jun 243,852-7856380
31 Mar 244,586-4696290
31 Dec 234,317-5096100
30 Sep 234,981-2585790
30 Jun 235,871605570
31 Mar 236,2852565330
31 Dec 227,7357365710
30 Sep 228,2979755860
30 Jun 227,3258835500
31 Mar 226,7698995130
31 Dec 215,8037084470
30 Sep 215,2305314180
30 Jun 215,7546194020
31 Mar 215,5876503940
31 Dec 205,6987233790
30 Sep 205,7867743540
30 Jun 205,6396483310
31 Mar 205,2874753090
31 Dec 194,8442912800
30 Sep 194,7812692740
30 Jun 194,5073312630
31 Mar 194,3823572620
31 Dec 184,2464022610
30 Sep 183,7813742480
30 Jun 183,6113252350
31 Mar 183,6763492290
31 Dec 173,2542122360
30 Sep 173,1191482280
30 Jun 173,0081922260
31 Mar 172,9871912130
31 Dec 163,167-291880
30 Sep 162,865-1141930
30 Jun 162,643-2061820
31 Mar 162,330501630
31 Dec 152,629-1152822
30 Sep 152,777612542
30 Jun 152,728841290
31 Mar 152,6691481340
31 Dec 142,2121312183
30 Sep 142,1471272173
30 Jun 142,156961170
31 Mar 142,070872123
31 Dec 132,179971845

Quality Earnings: 533138 is currently unprofitable.

Growing Profit Margin: 533138 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 533138 is unprofitable, and losses have increased over the past 5 years at a rate of 41.8% per year.

Accelerating Growth: Unable to compare 533138's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 533138 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).

Return on Equity

High ROE: 533138 has a negative Return on Equity (-35.49%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 05:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Astec LifeSciences Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAsian Markets Securities Private Limited
Ankur PeriwalAxis Capital Limited
Satish KumarCGS International